Enhancing CAR T-cell therapy manufacturing efficiency through semi-automated bioprocessing
{{output}}
Objectives: Chimeric antigen receptor (CAR) T-cell therapies have revolutionised the treatment of blood-based malignancies. The use of manual CAR T-cell manufacturing methods is one of the challenges that contributes to these del... ...
